JESSICA COLLINS: Open Payments
NPI 1285103689 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 29 payments from 8 companies in 2025. Trend: 2023 $43 · 2024 $409 · 2025 $720
Food & beverage: $635Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $248 |
| GENZYME CORPORATION | 2 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $150 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| PFIZER INC. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, ILUMYA, CIBINQO, COSENTYX, BOTOX, OTEZLA, YCANTH.
Industry payments across FL — which companies pay providers there.
